SFI — Sopharma Properties ADSITS Income Statement
0.000.00%
- BGN186.59m
- BGN185.80m
- BGN19.55m
- 99
- 49
- 21
- 58
Annual income statement for Sopharma Properties ADSITS, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.3 | 12.7 | 14.6 | 16.3 | 19.6 |
Cost of Revenue | |||||
Gross Profit | 7.6 | 9.45 | 10.8 | 12.2 | 15.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4 | 3.43 | 4.17 | 4.28 | 4.51 |
Operating Profit | 7.31 | 9.26 | 10.4 | 12 | 15 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.04 | 9.07 | 10.3 | 11.8 | 15.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.04 | 9.07 | 10.3 | 11.8 | 15.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.04 | 9.07 | 10.3 | 11.8 | 15.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.04 | 9.07 | 10.3 | 11.8 | 15.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.335 | 0.415 | 0.479 | 0.539 | 0.694 |
Dividends per Share |